Navigation Links
Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease
Date:10/3/2007

ide rights (except Japan) to a series of clinical and pre-clinical compounds that inhibit the enzymatic activity of members of the phospholipase A2 (PLA2) family -- a group of enzymes responsible for the release of arachidonic acid and subsequent production of leukotrienes prostacyclins and other mediators of inflammation. These highly potent compounds inhibit novel upstream steps in the inflammation cascade and have the potential to address a variety of diseases. For more information please visit http://www.anthera.com.

Contact:

Press Relations

(650) 931-8868

pr@anthera.com


'/>"/>
SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...re-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Boa...wn as DOR BioPharma, Inc., a late-stage biotechnol...consortium to develop thermostable technology to a.... Soligenix received a $9.4 million grant from the...ases (NIAID), a division of the National Institute...
(Date:11/19/2009)...- In response to an ever-increasing number of webs...eration Pangea II, involving 24 countries, was coo...tion,s International Medical Products Anti-Counter...s of buying medicines online. ,, The week long ...and the seizure of thousands of potentially harmfu...
(Date:11/19/2009)...wswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. ...e presentation will be webcast live during the 21s...ednesday, December 2, 2009 at 9:00 a.m. Eastern Ti... York Palace Hotel in New York and will be present...,, To access the live presentation via the Web,...
Breaking Medicine Technology:Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3VAs Suicide Prevention Message Carried on 21 000 Buses 49515 1Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis 4620 1Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis 4620 2Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis 4620 3Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis 4620 4Nestl 26eacute 3B Recalls Cookie Dough Products 49510 1Nestl 26eacute 3B Recalls Cookie Dough Products 49510 2
(Date:11/20/2009)... , , Pioneering Neurologist Closer to Unde...ON, Nov. 20 Dr. Jeremy ...cal School and neurologist at the Massachusetts Ge..., presented his laboratory,s research on the new f...of the MINDlink Foundation. ,, Dr. Schmahmann i...
(Date:11/20/2009)... , , PRINCETON, NJ, Nov. 20 /PRNewswire-F...d today that a Special Meeting of Shareholders wil...e of the Meeting is to consider approval of two sp... to approve and authorize the sale of all or subst...ly on the terms provided for in the asset purchase...
(Date:11/20/2009)... , , WASHINGTON, Nov. 20 /PRNewswire-USN...is urging senators to modify health care reform le...anguage regarding a health insurance individual co...ve and enforceable mandate will minimize adverse s...rating rules prescribed by the bill. ,, "The in...
(Date:11/20/2009)... , , WASHINGTON, Nov. 20 /PRNewswire-...holic Bishops urged the Senate to make essential c...place federal law on abortion funding and conscien...h care for immigrants and include strong provision...lled the Senate health care bill an "enormous disa...
(Date:11/20/2009)... , , QUINCY, Mass., Nov. 20 /PRNewswire/ -...op Supermarket Company removed from sale Shedd,s C...ccoli Rice and Shedd,s Country Crock ® Side D...d sulfite allergen. ,, The following code date...ock ® Side Dishes DELUXE Cheddar Broccoli Ric...
Breaking Medicine News(10 mins):Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2
...ccording to a new study, researchers, suggest that...ng pregnancy may be prone to have children with ce...rs stress, gestational diabetes is not itself a ri... authors of this study speculate that gestational ...
...ccording to researchers , there is a new study on ...tbreak that sickened 30 people across six Western ...rised to find that the outbreak of Salmonella sero...e on Emerging Infectious Diseases, told that the o...
...ccording to researchers, young men are putting the...r testicles for signs of tumors and are embarrasse...el a lump. //Authors from the Texas base their arg...lot in the lung which, following a postmortem, was...
...esearchers say that driving when sleepy increases ...y or death by eight times.A team at the University...mitted to hospital, or who had died, between 1999 ...ght times more likely to be involved in a serious ...
...esearchers at the Country University of Chicago, h...ensive, broad-spectrum antibiotic, Azithromycin, w...hitis, does not have any benefit.// They arbi...nd an albuterol inhaler. There was no difference i...
...ccording to a research, women who live at high alt...heir conclusions after finding lower concentration... health and youthfulness, in women living in the m... sea level. //They found concentrations of the hor...
Other Medicine News:Health News:Gestational Diabetes linked to Chromosomal defici 2Health News:Grapes, Melons Implicated in Outbreaks 2Health News:Patients with testicular cancer dying through unfamiliarity 2Health News:High Altitude ‘Speeds up ageing process 2
...iVue MP90 is designed to match the pace and unique...ilt on Philips strong heritage in patient monitori...lays has highly flexible screen configuration; an ...nical support tools such as Event Surveillance, EA...
...ds wireless capability to Welch Allyn's comprehens...exible Monitoring concept to provide vital signs d...ere. FlexNet links multiple devices such as ambula...bedside monitors to Acuity® Central Monitoring...
Spot Vital Signs
...le and easy-to-use 3800 and 3900/P pulse oximeters...y, the proprietary clinical patient motion algorit...roved performance:, ,The 3800 and 3900 pulse ... mechanical stress testing such as rough handling ...
Medicine Products: